Matrix metalloproteinases and the development of cancer

Chemistry and Biology

Volumn 3, Issue 11, 1996, Pages 895-904

  Coussens, Lisa M ^a   Werb, Zena ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030293598     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(96)90178-7     Document Type: Review

References (56)

1. Stetler-Stevenson, W., Aznavoorian, S. & Liotta, L. (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9, 541-73.
2. Jones, P., Schmidhauser, C. & Bissell, M. (1993). Regulation of gene expression and cell function by extracellular matrix. Crit. Rev. Euk. Gene Exp. 3, 137-154.
3. Ray, J. & Stetler-Stevenson, W. (1994). The role of matrix metalloproteases and their inhibitors in tumor invasion, metastasis and angiogenesis. Eur. Respir. J. 7, 2062-2072.
4. Powell, W. & Matrisian, L. (1996). Complex roles of matrix metalloproteinases in tumor progression. In Attempts to Understand Metastasis Formation I: Metastasis Related Molecules. (Gunthert, U. and Birchmeier, W., ed.), pp. 1-21, Springer-Verlag, New York.
5. Seiki, M. (1996). Membrane type-matrix metalloproteinase and tumor invasion. In: Attempts to Understand Metastasis Formation I: Metastasis Related Molecules. (Gunthert, U. and Birchmeier, W., ed.), pp. 23-32, Springer-Verlag, New York.
6. Takino, T., Sato, H., Shingawa, A. & Seiki, M. (1995). Identification of a second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J. Biol. Chem. 270, 23013-23020.
7. Hirose, T., Patterson, C., Pourmotabbed, T., Mainardi, C. & Hasty, K. (1993). Structure-function relationship of human neutrophil - collagenase: identification of regions responsible for substrate specificity and general proteinase activity. Proc. Natl. Acad. Sci. 90, 2569-2573.
8. Li, J., et al., & Cawston, T. (1995). Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed β-propelier. Structure 34, 541-549.
9. Murphy, G., et al., & Docherty, A. (1994). Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J. Biol. Chem. 269, 6632-6636.
10. Birkedal-Hänsen, H., et al., & Engler, J. (1993). Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4, 197-250.
11. Kishnani, N., Staskus, P., Yang, T., Masiarz, F. & Hawkes, S. (1995). Identification and characterization of human tissue inhibitor of metalloproteinase-3 and detection of three additional metalloproteinase inhibitor activities in extracellular matrix. Matrix. Biol. 14, 479-488.
12. Itoh, Y. & Nagase, H. (1995). Preferential inactivation of tissue inhibitor of metalloproteinase-1 that is bound to the precursor of matrix metalloproteinase-9 (progelatinase B) by human neutrophil elastase. J. Biol. Chem. 270, 16518-16521.
13. Birkedal-Hansen, H. (1995). Proleolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7, 728-735.
14. Springman, E., Angleton, E., Birkedal-Hansen, H. & Van Wart, H. (1990). Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a 'cysteine switch' mechanism for activation. Proc. Natl. Acad. Sci. USA 87, 364-368.
15. Stetler-Stevenson, W., Liotta, L. & Kleiner, D. (1993). Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7, 1434-1441.
16. Imai, K., et al., & Okada, Y. (1996). Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res. 56, 2707-2710.
17. Emmert-Buck, M., Emonard, H., Corcoran, M., Krutzsch, H., Foidart, J. & Stetler-Stevenson, W. (1995). Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complex. FEBS Lett 364, 28-32.
18. Will, H., Atkinson, S., Butler, G., Smith, B. & Murphy, G. (1996). The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. J. Biol. Chem. 271, 17119-17123.
19. Basbaum, C. & Werb, Z. (1996). Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr. Opin. Cell Biol. 8, 731-738.
20. Logan, S., Garabedian, M., Campbell, C. & Werb, Z. (1996). Synergistic transcriptional activation on the TIMP-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J. Biol. Chem. 271, 774-782.
21. Brooks, P., et al., & Cheresh, D. (1996). Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with αvβ3. Cell 85, 683-693.
22. Moscatelli, D. & Rifkin, D. (1988). Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochem. Biophys. Acta 948, 67-85.
23. Flaumenhaft, R. & Rifkin, D. (1991). Extracellular matrix regulation of growth factor and protease activity. Curr. Opin. Cell Biol. 3, 817-823.
24. Murray, G., Duncan, M., O'Neil, P., Melvin, W. & Fothergill. (1996). Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat. Med. 2, 461-462.
25. Heppner, K., Matrisian, L., Jensen, R. & Rogers, W. (1996). Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am. J. Pathol. 149, 273-262.
26. Wang, H., Rodgers, W., Chimell, M., Svitek, C. & Schwartz, H. (1995). Osteosarcoma oncogene expression detected by in situ hybridization. J. Orthoped. Res. 13, 671-678.
27. Wright, J., McDonnell, S., Portella, G., Bowden, G., Balmain, A. & Matrisian, L. (1994). A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol. Carcinog. 10, 207-215.
28. MacDougal, J. & Matrisian, L. (1995). Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14, 351-362.
29. Roskelley, C., Srebrow, A. & Bissell, M. (1995). A hierarchy of ECM-mediated signaling regulates tissue-specific gene expression. Curr. Opin. Cell Biol. 7, 736-747.
30. 1 a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc. Natl. Acad. Sci. 91, 5657-5661.
31. Kataoka, H., DeCastro, R., Zucker, S. & Biswas, C. (1993). Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72 kDa gelatinase. Cancer Res. 53, 3154-3158.
32. Fisher, G., et al., & Voorhees, J. (1996). Molecular basis of suninduced premature skin aging and retinoid antagonism. Nature 379, 335-339.
33. DeClerck, Y. & Imren, S. (1994). Protease inhibitors: role and potential therapeutic use in human cancer. Eur. J. Cancer A 30, 2170-2180.
34. Brown, P. (1993). Matrix metalloproteinase inhibitors: a new class of anticancer agent. Curr. Opin. Invest. 2, 617-626.
35. Soloway, P., Alexander, C., Werb, Z. & Jaenisch, R. (1996). Targeted mutagenesis of TIMP-1 reveals that experimental metastasis is influenced by the TIMP-1 genotype of the tumor but not by that of the host. Oncogene, in press.
36. Werb, Z., Ashkenas, J., MacAuley, A. & Wiesen, J. (1996). Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis. Braz. J. Med. Biol. Res. 29, 1087-1097.
37. Sympson, C., Bissell, M. & Werb, Z. (1995). Mammary gland tumor formation in transgenic animals overexpressing stromelysin-1. Sem. Cancer Biol. 6, 159-164.
38. Alexander, C., Howard, E., Bissell, M. & Werb, Z. (1996). Rescue of mammary epithelial cell apoptosis and entactin degradation by a TIMP-1 transgene. J. Cell Biol., in press.
39. D'Armenieto, J., et al., & Chada, K. (1995). Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol. Cell. Biol. 15, 5732-5739.
40. McDonneli, S., Navre, M., Coffey, R. & Matrisian, L. (1991). Expression and localization of the matrix metalloproteirsase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol. Carcinog. 4, 527-533.
41. Muschel, R., Tykocinski, M. & Padarathsingh, M. (1996). Link between tumor progression, proteases and cell motility. Am. J. Pathol. 149, 1073-1076.
42. Coussens, L., Hanahan, D. & Arbeit, J. (1996). Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am. J. Pathol., in press.
43. Hay, E. (1993). Extracellular matrix alters epithelial differentiation. Curr. Opin. Cell Biol. 5, 1029-1035.
44. Hanahan, D. & Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
45. Boudreau, N., Sympson, C., Werb, Z. & Bissell, M. (1995). Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267, 891-893.
46. Mignatti, P. & Rifkin, D. (1993). Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73, 161-195.
47. Okada, A., et al., & Basset, P. (1995). Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl. Acad. Sci. USA 92, 2730-2734.
48. Okada, Y. (1996). Purification and characterization of membrane-type matrix metalloproteinase-1. Connect. Tissue 28, 86.
49. Stolow, M., et al., & Shi, Y. (1996). Identification and characterization of a novel collagenase in Xenopus laevis: possible roles during frog development. Mol. Biol. Cell 7, 1471-1483.
50. Knauper, V., et al., & Murphy, G. (1996). Cellular mechanisms for procollagenase-3 (MMP-13) activation. J. Biol. Chem. 271, 17124-17131.
51. Gallegos, N., Smales, C., Savage, P., Hembry, R. & Boulos, P. (1995). The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer. Surg. Oncol., 4, 111-119.
52. Nomura, H., Fujimoto, N., Seiki, M., Mai, M. & Okada, Y. (1996). Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase-2 (gelatinase A) in human gastric carcinomas. Int. J. Cancer 69, 9-16.
53. Wagner, S., et al., & Atkinson, M. (1992). Expression of stromelysin-3 in stromal elements of human basal cell carcinoma. Diagn. Mol. Pathol. 1, 200-205.
54. Zeng, Z. & Guillem, J. (1995). Distinct pattern of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 mRNA in human colorectal cancer and liver metastases. Brit J. Cancer 72, 575-582.
55. Byrne, J., Tomasetto, C., Rouyer, N., Bellocq, J., Rio, M. & Basset, P. (1995). The tissue inhibitor of metalloproteinase-3 gene in breast carcinoma; identification of multiple polyadenylation sites and a stromal pattern of expression. Mol. Med. 1, 418-427.
56. Polette, M., et al., & Birembaul, P. (1996). MT-MMP expression and localization in human lung and breast cancers. Virchows Arch. 428, 29-35.